In the BioHarmony Drug Report Database

"Preview" Icon

Emtricitabine

Emtriva (emtricitabine) is a small molecule pharmaceutical. Emtricitabine was first approved as Emtriva on 2003-07-02. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections. Emtriva’s patent is valid until 2021-03-09 (FDA).

 

Trade Name

 

Emtriva
 

Common Name

 

emtricitabine
 

ChEMBL ID

 

CHEMBL885
 

Indication

 

hiv infections
 

Drug Class

 

Nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives

Image (chem structure or protein)

Emtricitabine structure rendering